Skip to content

Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00248716
Enrollment
200
Registered
2005-11-04
Start date
2007-02-28
Completion date
Unknown
Last updated
2008-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron Deficiency

Brief summary

Healthy toddlers (age 9-18 month) following a routine blood count will be placed in three groups: 1. Iron deficiency with no anemia 2. anemia 3. no anemia and no iron deficiency Following a nutritional questionnaire, parents of all toddlers will receive instruction regarding appropriate nutrition in the 2nd year of life. Groups 1 and 2 will randomly receive one of two preparations currently in use for treatment of iron deficiency in Israel (Aktiron 35 - Ferrous gluconate and Ferripel-3 - iron polysaccharide complex). Followup blood count will be taken 3 month after recruitment. The study aims to compare the effectiveness of the Iron preparations regarding compliance and efficacy. The hypothesis is that a significant difference will be detected between the two preparations.

Interventions

DRUGFerrous gluconate and iron polysaccharide complex

Children with anemia will receive 5mg per kg per day of one of study medications. Treatment period for 3 months

Sponsors

Soroka University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Months to 18 Months
Healthy volunteers
No

Inclusion criteria

* Healthy toddlers age 9-18 months

Exclusion criteria

* Toddlers with: chronic diseases, prematurity, inherited hematological disease.

Design outcomes

Primary

MeasureTime frame
Hemoglobin3 months

Countries

Israel

Contacts

Primary ContactJacob Urkin, MD, MPH
jacobur@clalit.org.il972-8-6477480

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026